Turan Çetin, Budak Ersin, Şenormancı Güliz, Evren Cüneyt, Ünal Süheyla, Açıkgöz Yalçınkaya Elvan, Senormanci Ömer
Department of Psychiatry, University of Health Sciences Bursa Yüksek İhtisas Training and Research Hospital, Bursa, Turkey.
Department of Psychology, İstanbul Gelişim University, Bursa, Turkey.
Psychiatry Clin Psychopharmacol. 2023 Sep 1;33(3):156-162. doi: 10.5152/pcp.2023.23671. eCollection 2023 Sep.
This study aims to investigate the validity and reliability of the Turkish adaptation of the 16-item Risk of Relapse Assessment Scale (RRAS) for methamphetamine abusers.
A total of 160 patients diagnosed with methamphetamine use disorder were included in this study to evaluate the validity and reliability of the scale. The comparison of the relationship between the Risk of Relapse Assessment Scale, the Substance Craving Scale, and the Relapse Prediction Scale was also carried out. The validity of the Risk of Relapse Assessment Scale was examined in the first step by exploratory factor analysis. The suitability of the data for exploratory factor analysis was evaluated by Kaiser-Meyer-Olkin test and Barlett's test. Cronbach's coefficient and corrected item-total correlation value were used to test the reliability of the scale. The validity results of Risk of Relapse Assessment Scale were tested by confirmatory factor analysis. The significance level was set at < .05 for all analyses.
Considering the examination of the internal consistency values of the Risk of Relapse Assessment Scale, Cronbach's value was detected to be 0.90, and Cronbach's value of the subscales ranged from 0.72 to 0.90. The study determined that the goodness of fit values for RRAS were / =2.13, < .001, goodness of fit index = 0.88, comparative fit index = 0.92, normed fit index = 0.86, Trucker-Lewis index = 0.90, root mean square error of approximation = 0.08, and standardized root mean squared residual = 0.06.
Our findings demonstrate that Risk of Relapse Assessment Scale is a valid and reliable measurement tool for assessing the risk of methamphetamine relapse in Turkish.
本研究旨在调查16项复发风险评估量表（RRAS）土耳其语版本用于甲基苯丙胺滥用者的有效性和可靠性。
本研究共纳入160例被诊断为甲基苯丙胺使用障碍的患者，以评估该量表的有效性和可靠性。同时还比较了复发风险评估量表、物质渴望量表和复发预测量表之间的关系。第一步通过探索性因素分析检验复发风险评估量表的有效性。通过Kaiser-Meyer-Olkin检验和Bartlett检验评估数据是否适合进行探索性因素分析。使用Cronbach系数和校正后的项目-总分相关值来检验该量表的可靠性。通过验证性因素分析检验复发风险评估量表的有效性结果。所有分析的显著性水平设定为< .05。
考虑到对复发风险评估量表内部一致性值的检验，检测到Cronbach值为0.90，各子量表的Cronbach值范围为0.72至0.90。研究确定RRAS的拟合优度值为χ²/df = 2.13，p < .001，拟合优度指数 = 0.88，比较拟合指数 = 0.92，规范拟合指数 = 0.86，Trucker-Lewis指数 = 0.90，近似均方根误差 = 0.08，标准化均方根残差 = 0.06。
我们的研究结果表明，复发风险评估量表是评估土耳其语人群甲基苯丙胺复发风险的有效且可靠的测量工具。
